Effectiveness of collaborative care for depression in human immunodeficiency virus clinics

Archives of Internal Medicine

Volumn 171, Issue 1, 2011, Pages 23-31

  Pyne, Jeffrey M ^a,b   Fortney, John C ^a,b   Curran, Geoffrey M ^a,b   Tripathi, Shanti ^a,b   Atkinson, J H ^c   Kilbourne, Amy M ^d   Hagedorn, Hildi J ^e   Rimland, David ^f   Rodriguez Barradas, Maria C ^g   Monson, Thomas ^h   Bottonari, Kathryn A ⁱ   Asch, Steven M ^j   Gifford, Allen L ^i,k  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b South Central Mental Illness Research Education and Clinical Center (MIRECC)   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ VA New England Healthcare System   (United States)

^j VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^k BOSTON UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH STATUS; HOSPITAL CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NURSE MANAGER; OUTCOME ASSESSMENT; PATIENT CARE; PHARMACIST; PRIORITY JOURNAL; PSYCHIATRIST; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; SINGLE BLIND PROCEDURE; SYMPTOM CHECKLIST 90; TREATMENT RESPONSE;

ADULT; ANTI-HIV AGENTS; ANTIDEPRESSIVE AGENTS; COOPERATIVE BEHAVIOR; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NURSE ADMINISTRATORS; ODDS RATIO; PATIENT CARE TEAM; PHARMACISTS; PRIMARY HEALTH CARE; PSYCHIATRY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 78651297186     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.395     Document Type: Article

References (68)

1. Rabkin JG. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep. 2008;5(4):163-171.
2. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158(5):725-730.
3. Kilbourne AM, Justice AC, Rabeneck L, Rodriguez-Barradas M, Weissman S, Team VP; VACS 3 Project Team. General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era. J Clin Epidemiol. 2001;54(1)(suppl 1):S22-S28.
4. Sueoka K, Goulet JL, Fiellin DA, et al. Depression symptoms and treatment among HIV infected and uninfected veterans. AIDS Behav. 2010;14(2):272-279.
5. Asch SM, Kilbourne AM, Gifford AL, et al; HCSUS Consortium. Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med. 2003;18(6):450-460.
6. Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms as predictors of medical outcomes in HIV infection: Multicenter AIDS Cohort Study. JAMA. 1993;270(21):2563-2567.
7. Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54(3):295-306. (Pubitemid 37267859)
8. Evans DL, Ten Have TR, Douglas SD, et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry. 2002;159(10):1752-1759.
9. Leserman J, Petitto JM, Gu H, et al. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med. 2002;32(6):1059-1073.
10. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8(3):261-269.
11. Gordillo V, del Amo J, Soriano V, González-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13(13):1763-1769.
12. Ickovics JR, Hamburger ME, Vlahov D, et al; HIV Epidemiology Research Study Group. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285(11):1466-1474.
13. Mayne TJ, Vittinghoff E, Chesney MA, Barrett DC, Coates TJ. Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med. 1996;156(19):2233-2238.
14. Moskowitz JT. Positive affect predicts lower risk of AIDS mortality. Psychosom Med. 2003;65(4):620-626.
15. Farinpour R, Miller EN, Satz P, et al. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol. 2003;25(5):654-670.
16. Brown JL, Vanable PA. Cognitive-behavioral stress management interventions for persons living with HIV: a review and critique of the literature. Ann Behav Med. 2008;35(1):26-40.
17. Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47(3):384-390.
18. Safren SA, O'Cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28(1):1-10.
19. Williams JW Jr, Gerrity M, Holsinger T, Dobscha S, Gaynes B, Dietrich A. Systematic review of multifaceted interventions to improve depression care. Gen Hosp Psychiatry. 2007;29(2):91-116.
20. Schoenbaum M, Unützer J, Sherbourne C, et al. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA. 2001;286(11):1325-1330. (Pubitemid 33015523)
21. Pyne JM, Rost KM, Zhang M, Williams DK, Smith J, Fortney J. Cost-effectiveness of a primary care depression intervention. J Gen Intern Med. 2003;18(6):432-441. (Pubitemid 36836672)
22. Liu CF, Hedrick SC, Chaney EF, et al. Cost-effectiveness of collaborative care for depression in a primary care veteran population. Psychiatr Serv. 2003;54(5):698-704.
23. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74(4):511-544.
24. Kirschner N, Barr MS. Specialists/subspecialists and the patient-centered medical home. Chest. 2010;137(1):200-204.
25. Phillips BR, Mole LA, Backus LI, Halloran JP, Chang SW. Caring for veterans with HIV disease: fiscal year 2002. http://www.publichealth.va.gov/ docs/caring-2002.pdf. Accessed August 31, 2010.
26. Fultz SL, Goulet JL, Weissman S, et al. Differences between infectious diseases-certified physicians and general medicine-certified physicians in the level of comfort with providing primary care to patients. Clin Infect Dis. 2005;41(5):738-743.
27. Fortney JC, Pyne JM, Edlund MJ, et al. A randomized trial of telemedicine-based collaborative care for depression. J Gen Intern Med. 2007;22(8):1086-1093.
28. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9):509-515.
29. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry. 1983;140(6):734-739.
30. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
31. Pyne JM, Asch SM, Lincourt K, et al. Quality indicators for depression care in HIV patients. AIDS Care. 2008;20(9):1075-1083.
32. Rost K, Nutting PA, Smith J, Werner JJ. Designing and implementing a primary care intervention trial to improve the quality and outcome of care for major depression. Gen Hosp Psychiatry. 2000;22(2):66-77.
33. Simon GE, VonKorff M, Rutter C, Wagner E. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ. 2000;320(7234):550-554.
34. Fortney JC, Pyne JM, Edlund MJ, Robinson DE, Mittal D, Henderson KL. Design and implementation of the telemedicine-enhanced antidepressant management study. Gen Hosp Psychiatry. 2006;28(1):18-26.
35. Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry. 1999;56(12):1109-1115.
36. Suehs B, Argo TR, Bendele SD, Crismon ML, Trivedi MH, Kurian B. Texas Medication Algorithm Project Procedural Manual: major depressive disorder algorithms. http://www.dshs.state.tx.us/mhprograms/pdf/TIMA-MDD-Manual-080608. pdf. Accessed November 30, 2009.
37. MDD Working Group. VA/DoD Clinical Practice Guideline for Management of Major Depressive Disorder (MDD). Version 2.0. http://www.healthquality.va.gov/ Major-Depressive-Disorder-MDD-Clinical-Practice-Guideline.asp. Accessed November 30, 2009.
38. Smith GR Jr, Burnam A, Burns BJ, Cleary P, Rost KM. Depression Outcomes Module (DOM). In: American Psychiatric Association, ed. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 2000:213-215.
39. Rost K, Smith GR, Burnam MA, Burns BJ. Measuring the outcomes of care for mental health problems: the case of depressive disorders. Med Care. 1992;30(5)(suppl):MS266-MS273.
40. Lecrubier Y, Sheehan DV, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI): a short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry. 1997;12(5):224-231. (Pubitemid 27298915)
41. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry. 1997;12(5):232-241. (Pubitemid 27298916)
42. Rost KM, Nutting P, Smith J, Werner J, Duan N. Improving depression outcomes in community primary care practice: a randomized trial of the quEST intervention: Quality Enhancement by Strategic Teaming. J Gen Intern Med. 2001;16(3):143-149.
43. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA. 2000;283(2):212-220.
44. Derogatis L. SCL-90-R: Administration, Scoring, and Procedures Manual. 3rd ed. Minneapolis, MN: National Computer Systems Inc; 1994.
45. Lave JR, Frank RG, Schulberg HC, Kamlet MS. Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psychiatry. 1998;55(7):645-651.
46. Simon GE, Katon WJ, VonKorff M, et al. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry. 2001;158(10):1638-1644.
47. Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53(10):924-932.
48. Unützer J, Katon W, Callahan CM, et al; IMPACT Investigators Improving Mood-Promoting Access to Collaborative Treatment. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288(22):2836-2845.
49. Simon GE, Ludman EJ, Rutter CM. Incremental benefit and cost of telephone care management and telephone psychotherapy for depression in primary care. Arch Gen Psychiatry. 2009;66(10):1081-1089.
50. Jones D, Kazis L, Lee A, et al. Health status assessments using the Veterans SF-12 and SF-36: methods for evaluating outcomes in the Veterans Health Administration. J Ambul Care Manage. 2001;24(3):68-86.
51. Kaplan RM, Bush JW, Berry CC. Health status: types of validity and the index of well-being. Health Serv Res. 1976;11(4):478-507.
52. Kaplan RM, Anderson JP. The general health policy model: an integrated approach. In: Spiker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1996:309-321.
53. Justice AC, Holmes W, Gifford AL, et al; Adult AIDS Clinical Trials Unit Outcomes Committee. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol. 2001;54(suppl 1):S77-S90.
54. Chesney MA, Ickovics JR, Chambers DB, et al; Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 2000;12(3):255-266.
55. Katon W, Russo J, Sherbourne C, et al. Incremental cost-effectiveness of a collaborative care intervention for panic disorder. Psychol Med. 2006;36(3):353-363.
56. Simon GE, Katon WJ, Lin EH, et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psychiatry. 2007;64(1):65-72.
57. Rollman BL, Belnap BH, LeMenager MS, et al. Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA. 2009;302(19):2095-2103.
58. Dobscha SK, Corson K, Perrin NA, et al. Collaborative care for chronic pain in primary care: a cluster randomized trial. JAMA. 2009;301(12):1242-1252.
59. Katon WJ, Von Korff M, Lin EH, et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry. 2004;61(10):1042-1049.
60. Ell K, Xie B, Quon B, Quinn DI, Dwight-Johnson M, Lee PJ. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol. 2008;26(27):4488-4496.
61. Kumar V, Encinosa W. Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients. Psychiatr Q. 2009;80(3):131-141.
62. Simon GE, Manning WG, Katzelnick DJ, Pearson SD, Henk HJ, Helstad CS. Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. Arch Gen Psychiatry. 2001;58(2):181-187.
63. Katon WJ, Schoenbaum M, Fan MY, et al. Cost-effectiveness of improving primary care treatment of late-life depression. Arch Gen Psychiatry. 2005;62(12):1313-1320.
64. Lu M, Safren SA, Skolnik PR, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008;12(1):86-94.
65. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42(7):649-652.
66. Atkinson M, Zibin S, Chuang H. Characterizing quality of life among patients with chronicmental illness: a critical examination of the self-report methodology. Am J Psychiatry. 1997;154(1):99-105.
67. Carrier E, Gourevitch MN, Shah NR. Medical homes: challenges in translating theory into practice. Med Care. 2009;47(7):714-722.
68. Fortney JC, Pyne JM, Edlund MJ, et al. Reasons for antidepressant non-adherence among veterans treated in primary care clinics. J Clin Psychiatry. In press.